Clinical Trial Update: Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial compared insulin produced by Novo Nordisk's current manufacturing process with insulin produced using the NN729 process in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED